Bimekizumab
M24662
Product group Antibodies
Overview
- SupplierAbMole BioScience
- Product NameBimekizumab
- Delivery Days Customer9
- Category SupplierAntibody
- CertificationResearch Use Only
- Scientific DescriptionBimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.
- Storage InstructionPlease store the product under the recommended conditions in the Certificate of Analysis.
- UNSPSC12352203